Sword Diagnostics Launches Detection Technology for Ultrasensitive Immunoassays
Sword Diagnostics announced today the launch of its proprietary Raman detection system for ultrasensitive immunoassays.
Read MoreMonth: January 2010
LeukoDx Chief Scientific Officer and Signs MOU for In-Licensing Technology
LeukoDx LP announces the appointment of Dr Bruce Davis, MD as Chief Scientific Officer of LeukoDx. The company is concurrently announcing the signing of a Memorandum of Understanding with Dr Davis’ company, Trillium Diagnostics, for in-licensing a patent and technology pertaining to quantifying CD64 at the point of care on LeukoDx’s compact flow cytometry platform.
Read MoreAbbott Receives EU Approval for Ovarian Cancer Diagnostic, FDA Pending
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe.
Read MoreMultimmune, Boulder Diagnostics Announce Collaboration on HSP70 POC Test
The HSP70 lateral flow point of care (POC) test is being developed to test for elevated HSP70 levels in the blood of cancer patients and to evaluate the correlation of this occurrence with the presence of the tumor specific HSP70 cell surface marker.
Read More
Instrumentation
ORTEC, Photron Inc
Read More